T
T. Diab
Publications - 5
Citations - 559
T. Diab is an academic researcher. The author has contributed to research in topics: Medicine & Disease burden. The author has an hindex of 2, co-authored 2 publications receiving 526 citations.
Papers
More filters
Journal ArticleDOI
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm.
A. Sibley,Kwang Hyub Han,A. Abourached,Laurentius A. Lesmana,Mihály Makara,Wasim Jafri,Riina Salupere,Abdullah M. Assiri,Adrian Goldis,Faisal Abaalkhail,Zaigham Abbas,A. Abdou,F. Al Braiki,F. Al Hosani,K. Al Jaberi,M. Al Khatry,M. A. Al Mulla,H. Al Quraishi,A. Al Rifai,Y. Al Serkal,Altaf Alam,Seyed Moayed Alavian,Hamad I. Al-Ashgar,S. Alawadhi,L. Al-Dabal,P. Aldins,Faleh Z. Al-Faleh,Abdullah S. Alghamdi,R. Al-Hakeem,Abdulrahman Aljumah,A. Almessabi,Adel Alqutub,Khalid Alswat,Ibrahim Altraif,M. Alzaabi,N. Andrea,Mohamed A. Babatin,A. Baqir,M. T. Barakat,Ottar M. Bergmann,Abdul Rahman Bizri,Sarah Blach,Asad Chaudhry,M. S. Choi,T. Diab,Samsuridjal Djauzi,E. S. El Hassan,S. El Khoury,Chris Estes,S. Fakhry,J. I. Farooqi,J. I. Farooqi,H. Fridjonsdottir,Rino Alvani Gani,A. Ghafoor Khan,Liana Gheorghe,Magnus Gottfredsson,S. Gregorcic,Jessie Gunter,Behzad Hajarizadeh,Behzad Hajarizadeh,Saeed Hamid,Irsan Hasan,Almoutaz Hashim,Gabor Horvath,Béla Hunyady,R. Husni,Agita Jeruma,Jon G. Jonasson,Jon G. Jonasson,B. Karlsdottir,Do Young Kim,Young Seok Kim,Z. Koutoubi,Valentina Liakina,Valentina Liakina,Young-Suk Lim,A. Löve,A. Löve,Matti Maimets,Reza Malekzadeh,Mojca Maticic,Muhammad S. Memon,Shahin Merat,Jacques E Mokhbat,Fadi H. Mourad,David H. Muljono,David H. Muljono,Arif Nawaz,N. Nugrahini,S. Olafsson,S. Priohutomo,H. Qureshi,P. Rassam,Homie Razavi,Devin Razavi-Shearer,Kathryn Razavi-Shearer,Baiba Rozentale,M. Sadik,K. Saeed,A. Salamat,Faisal M. Sanai,A. Sanityoso Sulaiman,R. A. Sayegh,Ala I. Sharara,M. Siddiq,A. M. Siddiqui,G. Sigmundsdottir,B. Sigurdardottir,Danute Speiciene,Andri Sanityoso Sulaiman,Marwa Sultan,M. Taha,Junko Tanaka,H. Tarifi,G. Tayyab,Ieva Tolmane,M. Ud Din,M. Umar,M. Umar,M. Umar,Jonas Valantinas,J. Videčnik-Zorman,Cesar Yaghi,Evy Yunihastuti,M. A. Yusuf,Bader Faiyaz Zuberi,Jonathan Schmelzer +127 more
TL;DR: The current treatment rate and efficacy are not sufficient to manage the disease burden of hepatitis C virus and alternative strategies are required to keep the number of HCV individuals with advanced liver disease and liver‐related deaths from increasing.
Journal ArticleDOI
Strategies to manage hepatitis C virus infection disease burden - Volume 3
Faleh Z. Al-Faleh,N. Nugrahini,Mojca Matičič,Ieva Tolmane,M. Alzaabi,Behzad Hajarizadeh,Behzad Hajarizadeh,Jonas Valantinas,Do Young Kim,Béla Hunyady,Faisal Abaalkhail,Zaigham Abbas,A. Abdou,A. Abourached,F. Al Braiki,F. Al Hosani,K. Al Jaberi,M. Al Khatry,M. A. Al Mulla,H. Al Quraishi,A. Al Rifai,Y. Al Serkal,Altaf Alam,Hamad I. Al-Ashgar,Seyed M Alavian,S. Alawadhi,L. Al-Dabal,P. Aldins,Abdullah S. Alghamdi,R. Al-Hakeem,Abdulrahman Aljumah,A. Almessabi,Adel Alqutub,Khalid Alswat,Ibrahim Altraif,N. Andrea,Abdullah M. Assiri,Mohamed A. Babatin,A. Baqir,M. T. Barakat,Ottar M. Bergmann,Abdul Rahman Bizri,Asad Chaudhry,Moon Suk Choi,T. Diab,Samsuridjal Djauzi,E. S. El Hassan,S. El Khoury,Chris Estes,S. Fakhry,Javed Iqbal Farooqi,Javed Iqbal Farooqi,H. Fridjonsdottir,Rino Alvani Gani,A. Ghafoor Khan,Liana Gheorghe,Adrian Goldis,Magnus Gottfredsson,S. Gregorcic,Jessie Gunter,Saeed Hamid,Kwang Hyub Han,Irsan Hasan,Almoutaz Hashim,Gabor Horvath,R. Husni,Wasim Jafri,Agita Jeruma,Jon G. Jonasson,Jon G. Jonasson,B. Karlsdottir,Young Seok Kim,Z. Koutoubi,Laurentius A. Lesmana,Valentina Liakina,Valentina Liakina,Young-Suk Lim,A. Löve,A. Löve,Matti Maimets,Mihály Makara,Reza Malekzadeh,Muhammad S. Memon,Shahin Merat,Jacques E Mokhbat,Fadi H. Mourad,David H. Muljono,David H. Muljono,Arif Nawaz,S. Olafsson,S. Priohutomo,H. Qureshi,P. Rassam,Homie Razavi,Devin Razavi-Shearer,Kathryn Razavi-Shearer,Baiba Rozentale,M. Sadik,K. Saeed,A. Salamat,Riina Salupere,Faisal M. Sanai,A. Sanityoso Sulaiman,R. A. Sayegh,Jonathan Schmelzer,Ala I. Sharara,A. Sibley,M. Siddiq,A. M. Siddiqui,G. Sigmundsdottir,B. Sigurdardottir,Danute Speiciene,Andri Sanityoso Sulaiman,Marwa Sultan,M. Taha,Junko Tanaka,H. Tarifi,G. Tayyab,M. Ud Din,M. Umar,M. Umar,J. Videčnik-Zorman,Cesar Yaghi,Evy Yunihastuti,M. A. Yusuf,Bader Faiyaz Zuberi,Sarah Blach +126 more
TL;DR: A 90% reduction in total HCV infections within 15 years is feasible in most countries studied, but it required a coordinated effort to introduce harm reduction programmes to reduce new infections, screening to identify those already infected and treatment with high cure rate therapies.
Journal ArticleDOI
Detection of Occult Hepatitis C Virus Infection in Egyptian Patients Who Achieved a Sustained Virologic Response to Direct-Acting Antiviral Agents
Ahmed R. Mashaal,Mohamed Abd Elhameed,Ahmed El Ray,T. Diab,Reham M. Dawood,Mohamed Shemis,Moataz S. Seyam +6 more
TL;DR: The presence of Occult HCV infection (OCI) was significantly correlated with age, level of AFP, and the degree of liver stiffness; and monitoring and follow-up of those patients may help to assess the outcomes.
Journal ArticleDOI
Rate of Epstein-Barr Virus in Gastric Adenocarcinoma in Egyptian Patients in View of the WHO Classification and Correlation with p16 Immunoreactivity
Safia Samir,Hend O. Ahmed,T. Diab,Amr A. Mostafa,Hesham A Elmeligy,Amira A Kamel,Heba Khalil +6 more
TL;DR: EBVaGC has a low incidence in Egypt; loss of p16 expression was recognized in EB VaGC and could be considered as a promising biomarker of EBVaGC and the combination of the two methods IHC and qPCR in addition to p16 is recommended for improving the accuracy of identification of infected cancer.